Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bonnie Ky

Showing results (31-40 of 312) with videos related to

Pageof 32
Sort By:
JACC. Cardiooncology|March 6, 2023
The ESC 2022 Cardio-Oncology Guidelines and the Road Ahead in Cardio-OncologyRichard K Cheng, Bonnie Ky
Clinical Cardiology|March 11, 2005
The effects of statin therapy on plasma markers of inflammation in patients without vascular diseaseBonnie Ky, Daniel J Rader
JACC. Cardiovascular Interventions|May 21, 2021
Adding Precision to Defining Bleeding and Ischemic Risk With PCI in Cancer PatientsBonnie Ky, Alexander C Fanaroff
JACC. Basic to Translational Science|April 21, 2020
COVID-19 Clinical Trials: A Primer for the Cardiovascular and Cardio-Oncology CommunitiesBonnie Ky, Douglas L Mann
Heart Failure Clinics|July 14, 2011
Biomarker approach to the detection and cardioprotective strategies during anthracycline chemotherapyBonnie Ky, Joseph R Carver
JAMA Network Open|February 5, 2026
Improving Cardiovascular Risk Factors in Survivors of CancerStephanie B Dixon, Bonnie Ky
Trends in Cardiovascular Medicine|February 13, 2019
Cardioprotective strategies to prevent breast cancer therapy-induced cardiotoxicityAllison Padegimas, Suparna Clasen, Bonnie Ky
Journal of the American College of Cardiology|December 16, 2017
Reply: Statistical Analyses of Arginine-Nitric Oxide Metabolites and Cardiac DysfunctionMary Putt, Brian S Finkelman, Bonnie Ky
Seminars in Oncology|April 2, 2013
Asymptomatic cardiac toxicity in long-term cancer survivors: defining the population and recommendations for surveillanceJoseph R Carver, Dava Szalda, Bonnie Ky
Urologic Oncology|May 21, 2019
Cardiovascular toxicities of therapy for genitourinary malignanciesVivek Narayan, David J Vaughn, Bonnie Ky
Pageof 32

Showing results (31-40 of 312) with videos related to

Sort By:
Pageof 32
JACC. Cardiooncology|March 6, 2023
The ESC 2022 Cardio-Oncology Guidelines and the Road Ahead in Cardio-OncologyRichard K Cheng, Bonnie Ky
Clinical Cardiology|March 11, 2005
The effects of statin therapy on plasma markers of inflammation in patients without vascular diseaseBonnie Ky, Daniel J Rader
JACC. Cardiovascular Interventions|May 21, 2021
Adding Precision to Defining Bleeding and Ischemic Risk With PCI in Cancer PatientsBonnie Ky, Alexander C Fanaroff
JACC. Basic to Translational Science|April 21, 2020
COVID-19 Clinical Trials: A Primer for the Cardiovascular and Cardio-Oncology CommunitiesBonnie Ky, Douglas L Mann
Heart Failure Clinics|July 14, 2011
Biomarker approach to the detection and cardioprotective strategies during anthracycline chemotherapyBonnie Ky, Joseph R Carver
JAMA Network Open|February 5, 2026
Improving Cardiovascular Risk Factors in Survivors of CancerStephanie B Dixon, Bonnie Ky
Trends in Cardiovascular Medicine|February 13, 2019
Cardioprotective strategies to prevent breast cancer therapy-induced cardiotoxicityAllison Padegimas, Suparna Clasen, Bonnie Ky
Journal of the American College of Cardiology|December 16, 2017
Reply: Statistical Analyses of Arginine-Nitric Oxide Metabolites and Cardiac DysfunctionMary Putt, Brian S Finkelman, Bonnie Ky
Seminars in Oncology|April 2, 2013
Asymptomatic cardiac toxicity in long-term cancer survivors: defining the population and recommendations for surveillanceJoseph R Carver, Dava Szalda, Bonnie Ky
Urologic Oncology|May 21, 2019
Cardiovascular toxicities of therapy for genitourinary malignanciesVivek Narayan, David J Vaughn, Bonnie Ky
Pageof 32